Search

Global efforts led by The Kids Research Institute Australia’s Child Health Analytics program will see nations impacted by high rates of malaria empowered to develop their own controls and solutions.

One hundred years after the discovery of insulin, technology advancements are being heralded as the dawn of a new era for managing type 1 diabetes (T1D) in young people.

The Kids Research Institute Australia researchers are urging governments to listen more to what kids need.

Despite major advances in science in recent years, many Australians still don't understand the magnitude and importance of early years development to a child's life journey.

World-first findings from the collaborative REACT study – a joint project between The Kids, PCH, UWA and Curtin University – have led to the asthma medication Ventolin being routinely given to paediatric patients before tonsillectomy surgery to prevent respiratory complications.

Discover more about some of the broad topics and areas of research that The Kids Research Institute Australia are involved in.

In early 2021, The Kids Research Institute Australia researcher Dr Amy Finlay-Jones led a global team in trying to answer that question to help better prioritise mental health spending.
Research
Does lung function in preschoolers help to predict asthma in later life?The earliest respiratory function assessments, within or close to the neonatal period, consistently show correlations with lung function and with the development of asthma into adulthood. Measurements of lung function in infancy reflect the in utero period of lung development, and if early enough, show little influence of postnatal environmental exposures.
Research
Anaphylactic Reactions During Bee Venom Immunotherapy in the Paediatric PopulationA retrospective study will review episodes of anaphylaxis during bee venom immunotherapy in children, any modifications made to the dosing schedule, and the subsequent outcomes over a nine-year period in Western Australia.
Research
Mapping Drug-Resistant Tuberculosis Treatment Outcomes in Hunan Province, ChinaDrug-resistant tuberculosis (DR-TB) remains a major public health challenge in China, with varying treatment outcomes across different regions. Understanding the spatial distribution of DR-TB treatment outcomes is crucial for targeted interventions to improve treatment success in high-burden areas such as Hunan Province. This study aimed to map the spatial distribution of DR-TB treatment outcomes at a local level and identify sociodemographic and environmental factors associated with poor treatment outcomes in Hunan Province, China.